NCT02872818View on ClinicalTrials.gov

Apoptotic Signaling Pathways in Rats With Endometrial Hyperplasia

PHASE4CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

October 31, 2014

Primary Completion Date

March 31, 2015

Study Completion Date

March 31, 2015

Conditions
Apoptotic Signal Pathways in Endometrial Hyperplasia
Interventions
DRUG

17β estradiol hemihydrate

4mg/kg/day for 20 days

DRUG

Metformin

50 mg/kg/day last 10 days

DRUG

medroxyprogesterone acetate

1mg/kg/day last 10 days

Trial Locations (1)

38000

Kayseri Training and Research Hospital, Kayseri

All Listed Sponsors
lead

Kayseri Education and Research Hospital

OTHER_GOV

NCT02872818 - Apoptotic Signaling Pathways in Rats With Endometrial Hyperplasia | Biotech Hunter | Biotech Hunter